Search results
-
Vicarsa (B): Arreglando un error en la venta
Torres, Óscar; Palencia, LuisCase ASN-37Service and Operations ManagementLa parte (B) de este caso suministra información no conocida durante la parte (A) e invita por ello a reflexionar sobre la cautela con la que hay que establecer soluciones en situaciones con información incompleta.Starting at €5.74
-
Vicarsa (B): What Went Wrong with the Sale
Torres, Óscar; Palencia, LuisCase ASN-37-EService and Operations ManagementPart (B) of this case provides information not previously available in Part (A), leading to a chance to reflect on the caution necessary in solving problems with incomplete information.Starting at €5.74
-
Vicarsa (A): What Went Wrong with the Sale
Torres, Óscar; Palencia, LuisCase ASN-36-EService and Operations ManagementA sales representative sees what could have been an important contract running the risk of being cancelled due to the rush to try to close a related sale. The analysis of the sales process and the identification of the mistakes made provide the basis for proposing a solution. The information available is limited, and this should be taken into account during the discussion.Starting at €8.20
-
Vicarsa (A): Arreglando un error en la venta
Torres, Óscar; Palencia, LuisCase ASN-36Service and Operations ManagementUn agente de ventas ve cómo lo que podía haber sido un importante contrato corre peligro de cancelarse debido a la precipitación en intentar cerrar una venta relacionada. El análisis del proceso de la venta y la identificación de los errores es la base para proponer soluciones. La información con la que se cuenta es limitada, y eso debe tenerse en cuenta en la discusión.Starting at €8.20
-
Corning: 156 Years of Innovation
Bowen, H. Kent; Purrington, CourtneyCase HBS-608108-EService and Operations ManagementThe executive team at Corning has committed to double the rate of new business creation per decade, while at the same time growing the company's current businesses, including glass substrates for LCD displays. Their strategy, built on more than 150 years of successful innovation, is to invent "keystone components" which uniquely enable other companies' products and earn high margins from its proprietary technology. As part of the company's missio...Starting at €8.20
-
Novartis AG: Science-Based Business
Bowen, H. Kent; Purrington, CourtneyCase HBS-608136-EService and Operations ManagementNovartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in 2007. Pharmaceuticals account for slightly over $24B of that total. In 2007, corporate R&D spending was $6.43B, or almost 17% of net sales. Novartis executive leaders believe in scientific progress and that large-scale investments in science will therefore r...Starting at €8.20